Pharma Sector Overview
| Sun Pharmaceutical Industries Ltd. | 9.47% | 8.42% | 10.80% | 22.53% | 30.18% | 30.14% | -19.49% | 14.29% | 16.55% | 20.85% | 4,04,383.08 Cr |
| Dr. Reddy's Laboratories Ltd. | 11.38% | 16.54% | 14.86% | 28.75% | 29.61% | 27.09% | 1.91% | 1.27% | 16.45% | 17.54% | 1,07,227.47 Cr |
| Cipla Ltd. | 3.94% | 6.88% | 133.05% | 29.27% | 28.92% | 17.97% | 10.22% | 27.89% | 18.56% | 19.13% | 1,26,529.36 Cr |
| Lupin Ltd. | 11.93% | 13.48% | 11.45% | 28.82% | 24.13% | 11.23% | 51.88% | 71.11% | 19.49% | 14.56% | 87,108.04 Cr |
| Biocon Ltd. | 14.83% | 3.43% | 23.09% | 21.02% | 29.93% | 27.34% | -95.28% | -1.05% | 2.26% | 9.37% | 43,671.82 Cr |
| Divi's Laboratories Ltd. | 13.79% | 19.31% | -52.90% | 35.19% | 35.47% | 34.09% | 26.48% | 36.93% | 22.61% | 23.41% | 1,69,515.23 Cr |
| Piramal Pharma Ltd. | -0.89% | 11.99% | 140.74% | 11.64% | 18.06% | 13.32% | 7.46% | 392.86% | -4.22% | 1.00% | 26,615.76 Cr |
| Emcure Pharmaceuticals Ltd. | 15.72% | N/A | 10.48% | 19.68% | 19.26% | 19.43% | 37.36% | N/A | 10.23% | 8.96% | 25,007.97 Cr |
| Jubilant Pharmova Ltd. | 9.76% | 7.93% | 5.68% | 15.86% | 26.94% | 14.81% | -78.68% | 988.09% | 5.39% | 11.56% | 17,770.98 Cr |
| Alembic Pharmaceuticals Ltd. | 9.54% | 7.12% | 132.54% | 16.80% | 16.15% | 15.15% | 14.77% | -5.27% | 8.98% | 8.72% | 17,795.83 Cr |
| Laurus Labs Ltd. | 31.35% | 10.18% | 124.09% | 25.05% | 20.42% | 23.84% | 1213.04% | 123.15% | 10.30% | 6.45% | 51,414.98 Cr |
| Ajanta Pharma Ltd. | 13.78% | 10.44% | 140.51% | 28.99% | 29.13% | 19.61% | 4.61% | 13.48% | 19.60% | 19.80% | 29,804 Cr |
| JB Chemicals & Pharmaceuticals Ltd. | 8.91% | 12.45% | -45.53% | 28.83% | 27.31% | 24.62% | 14.05% | 19.04% | 18.50% | 16.83% | 26,177.09 Cr |
| Glaxosmithkline Pharmaceuticals Ltd. | -1.16% | 8.56% | -51.46% | 36.63% | 35.55% | 27.00% | 12.45% | 57.22% | 25.46% | 24.74% | 45,073.85 Cr |
| Eris Lifesciences Ltd. | 7.40% | 44.02% | 29.03% | 36.26% | 35.79% | 32.97% | 41.73% | -10.31% | 16.18% | 12.95% | 21,956.28 Cr |
| Dishman Carbogen Amcis Ltd. | 35.18% | 3.66% | 133.11% | 22.62% | 16.76% | 15.01% | 130.10% | 102.15% | 3.31% | 0.12% | 4,585.12 Cr |
| Marksans Pharma Ltd. | 4.97% | 20.46% | 20.72% | 17.06% | 22.84% | 21.20% | -34.18% | 21.39% | 9.39% | 14.59% | 8,268.88 Cr |
| Aarti Drugs Ltd. | 6.33% | -5.60% | -54.22% | 12.60% | 12.71% | 12.39% | 63.26% | -1.13% | 9.14% | 7.04% | 4,396.48 Cr |
| Aarti Pharmalabs Ltd. | -30.48% | 14.17% | -43.93% | 24.61% | 22.43% | 20.41% | -10.78% | 25.62% | 12.82% | 12.88% | 7,581.13 Cr |
| IOL Chemicals And Pharmaceuticals Ltd. | 9.82% | -2.51% | 111.94% | 12.60% | 10.81% | 11.45% | 13.73% | -24.89% | 6.15% | 4.86% | 2,724.82 Cr |
| Caplin Point Laboratories Ltd. | 11.17% | 14.37% | 148.05% | 39.38% | 38.37% | 36.25% | 23.16% | 17.25% | 29.55% | 27.93% | 15,243.39 Cr |
| Hikal Ltd. | -6.49% | 4.21% | -1.44% | 6.86% | 17.93% | 15.33% | -543.90% | 30.50% | -5.89% | 4.88% | 2,959.22 Cr |
| Morepen Laboratories Ltd. | -6.59% | 7.17% | -51.07% | 6.72% | 10.62% | 8.96% | -71.83% | 17.02% | 2.68% | 6.51% | 2,654.84 Cr |
| Sai Life Sciences Ltd. | 77.47% | 15.66% | 24.91% | 26.36% | 26.11% | 21.31% | 491.89% | 93.22% | 12.18% | 10.04% | 18,688.48 Cr |
| Nectar Lifesciences Ltd. | -21.88% | -0.74% | 0.08% | -18.09% | -1.29% | 4.68% | -2269.23% | -2404.55% | -18.58% | -5.95% | 336.62 Cr |
| Sequent Scientific Ltd. | 13.12% | 13.26% | 3.17% | 12.13% | 10.73% | 5.81% | 119.23% | 161.11% | 3.98% | 2.08% | 5,127.69 Cr |
| Neuland Laboratories Ltd. | -33.40% | -5.24% | -46.25% | 14.46% | 33.62% | 25.80% | -85.80% | -13.32% | 4.75% | 17.61% | 20,190.41 Cr |
| Onesource Specialty Pharma Ltd. | 11.97% | 740.42% | 124.22% | 26.89% | 18.15% | -141.16% | 96.08% | 98.27% | -0.06% | -1.20% | 20,373.04 Cr |
| Shilpa Medicare Ltd. | 9.90% | 11.71% | -51.75% | 30.26% | 21.98% | 19.93% | 228.08% | 119.07% | 14.59% | 6.09% | 3,536.12 Cr |
| Solara Active Pharma Sciences Ltd. | -12.20% | -0.40% | 116.31% | 18.17% | 16.72% | 6.86% | 170.29% | 100.09% | 3.30% | 0.04% | 2,820.95 Cr |
| Innova Captab Ltd. | 19.46% | 15.02% | 15.82% | 16.10% | 15.94% | 13.57% | 5.24% | 20.10% | 8.82% | 10.31% | 4,635.22 Cr |
| Cohance Lifesciences Ltd. | 138.12% | 13.91% | -55.07% | 20.02% | 36.22% | 42.32% | -35.35% | -10.85% | 8.45% | 22.11% | N/A |
| Acutaas Chemicals Ltd. | 17.30% | 40.34% | -42.15% | 32.26% | 24.73% | 21.42% | 195.63% | 239.79% | 21.24% | 15.93% | N/A |
| Bliss GVS Pharma Ltd. | 12.97% | 5.13% | -52.33% | 37.01% | 20.15% | 20.47% | 107.11% | 10.93% | 21.38% | 11.15% | 1,595.62 Cr |
| Advanced Enzyme Technologies Ltd. | 20.31% | 2.09% | 6.36% | 35.11% | 35.72% | 36.16% | 17.05% | -1.68% | 21.75% | 21.04% | 3,430.27 Cr |
| Kopran Ltd. | -3.03% | 2.44% | -49.10% | 12.34% | 12.21% | 12.18% | -33.04% | -24.41% | 5.51% | 6.12% | 797.44 Cr |
| Wanbury Ltd. | 24.47% | 4.15% | -51.05% | 15.19% | 13.31% | 10.18% | 1187.50% | -45.50% | 8.27% | 5.09% | 838.92 Cr |
| Ind-Swift Laboratories Ltd. | 360.51% | -56.15% | -62.18% | 11.99% | 90.50% | 22.57% | -70.51% | -59.15% | 5.74% | 44.59% | 629.95 Cr |
| Sudarshan Pharma Industries Ltd. | 46.43% | 8.95% | -47.90% | 8.43% | 7.29% | 4.03% | 420.00% | 37.50% | 2.73% | 3.16% | N/A |
| Syncom Formulations (India) Ltd. | 33.98% | 76.55% | -40.40% | 18.75% | 15.39% | 15.75% | 90.91% | 67.65% | 13.48% | 10.63% | 1,560.4 Cr |
| Fredun Pharmaceuticals Ltd. | N/A | N/A | N/A | 14.18% | 12.03% | N/A | N/A | N/A | 5.65% | 4.33% | N/A |
| Senores Pharmaceuticals Ltd. | 71.65% | 85.65% | 204.04% | 27.19% | 27.36% | 31.45% | 35.69% | 17.92% | 15.35% | 14.65% | 3,574.91 Cr |
| Kwality Pharmaceuticals Ltd. | 39.21% | 20.52% | -56.71% | 22.02% | 22.23% | 23.26% | 42.91% | 68.54% | 10.69% | 10.75% | N/A |
| Beta Drugs Ltd. | N/A | 22.54% | -41.80% | N/A | 19.84% | 22.70% | N/A | 10.87% | N/A | 11.71% | N/A |
| Bharat Parenterals Ltd. | 25.39% | 32.26% | -45.65% | 12.79% | 4.21% | 13.98% | 91.37% | -367.20% | -0.75% | -12.83% | N/A |
| Mangalam Drugs And Organics Ltd. | -25.07% | -13.66% | N/A | -7.81% | 11.41% | N/A | -612.94% | 174.17% | -24.06% | 2.11% | 102.22 Cr |
| Hester Biosciences Ltd. | 2.23% | 2.15% | 9.80% | 31.13% | 22.20% | 22.17% | 131.02% | 36.21% | 20.56% | 9.27% | 1,382.36 Cr |
| Alembic Ltd. | -2.03% | 40.89% | -34.29% | 134.67% | 150.84% | 76.36% | 10.60% | 15.68% | 123.90% | 140.01% | 2,556.78 Cr |
| Kilitch Drugs (India) Ltd. | 28.96% | 28.47% | -44.21% | 13.50% | 21.49% | 18.35% | 126.51% | 81.03% | 5.24% | 12.58% | 646.67 Cr |
| Parnax Lab Ltd. | 6.50% | -0.52% | -89.52% | 14.28% | 15.15% | 13.80% | -17.87% | 19.93% | 6.14% | 6.15% | N/A |
| Sakar Healthcare Ltd. | 28.16% | 15.80% | -48.26% | 24.84% | 28.66% | 26.71% | 91.82% | 41.31% | 8.86% | 9.86% | 778.23 Cr |
| Natural Capsules Ltd. | 15.37% | 8.87% | -49.96% | 1.50% | 10.77% | 15.30% | -930.77% | -96.47% | -12.34% | 0.36% | N/A |
| Gennex Laboratories Ltd. | 20.68% | 59.03% | -98.69% | 21.51% | 19.47% | 14.90% | 4.76% | 19.40% | 14.68% | 13.14% | N/A |
| Valiant Laboratories Ltd. | 147.95% | -26.74% | N/A | 6.52% | 0.57% | 4.41% | 450.00% | -492.31% | 3.89% | -1.65% | 364.63 Cr |
| Makers Laboratories Ltd. | 18.28% | 15.67% | -54.38% | 9.37% | 15.48% | 8.28% | 144.31% | 219.59% | 3.67% | 9.03% | N/A |
| Vivimed Labs Ltd. | -27.18% | -22.00% | -21.16% | 0.45% | -7.46% | -40.74% | 64.13% | 29.74% | -25.68% | -27.49% | N/A |
| Alpa Laboratories Ltd. | -10.88% | 3.41% | -53.56% | 64.72% | 24.99% | 21.63% | 130.99% | 16.60% | 61.58% | 17.34% | 189.22 Cr |
| Shree Ganesh Remedies Ltd. | -0.45% | -13.74% | N/A | 32.26% | 39.54% | 32.97% | -25.97% | -19.61% | 13.97% | 21.24% | N/A |
| Sotac Pharmaceuticals Ltd. | N/A | -6.59% | -49.01% | N/A | 18.08% | 12.23% | N/A | 86.15% | N/A | 9.56% | N/A |
| ANG Lifesciences India Ltd. | 33.64% | -36.45% | -70.30% | 2.98% | -0.28% | 6.28% | 35.32% | -23.78% | -8.15% | -13.37% | N/A |
| Trident Lifeline Ltd. | 79.45% | 94.86% | -26.35% | 27.62% | 26.55% | 20.59% | 33.67% | 85.14% | 11.79% | 12.07% | N/A |
| Brooks Laboratories Ltd. | 42.26% | 3.86% | -55.10% | 40.29% | -8.68% | -16.99% | 445.74% | 51.50% | 37.57% | -12.07% | 319.58 Cr |
| Deccan Health Care Ltd. | 67.92% | 25.66% | -39.06% | 3.42% | 4.21% | 4.97% | -44.44% | -32.50% | 1.07% | 1.54% | N/A |
| Walpar Nutritions Ltd. | N/A | 14.78% | -35.51% | N/A | 8.34% | 7.56% | N/A | 47.62% | N/A | 3.90% | N/A |
| Sanjivani Paranteral Ltd. | 8.85% | N/A | N/A | 15.00% | 16.50% | N/A | -0.68% | N/A | 9.67% | 11.55% | N/A |
| Vivo Bio Tech Ltd. | 23.47% | 2.69% | -55.05% | 44.96% | 54.24% | 40.08% | 572.73% | 180.00% | 10.69% | 15.60% | N/A |
| Concord Drugs Ltd. | 16.36% | 0.73% | -57.50% | 7.47% | 9.17% | 9.16% | 300.00% | -27.66% | 0.87% | 0.74% | N/A |
| Medicamen Organics Ltd. | N/A | N/A | N/A | N/A | 17.50% | N/A | N/A | N/A | N/A | 10.60% | N/A |
| Decipher Labs Ltd. | -60.70% | -36.98% | -67.41% | -113.03% | -26.14% | 5.77% | -460.64% | -203.01% | -117.20% | -22.47% | N/A |
| Suven Life Sciences Ltd. | 85.59% | -43.08% | -61.70% | -2686.02% | -2326.86% | -1368.14% | -82.95% | -52.90% | -2759.35% | -2415.04% | 4,230.64 Cr |
Pharma Sector Summary
Revenue Growth (YoY)
9.71%
Average ROE
N/A
Average ROCE
N/A
EBITDA Margin
24.72%
PAT Margin
14.38%
EBITDA Margin (3Y)
N/A
PAT Margin (3Y)
N/A
Total Companies
70
* Q3 represents quarterly (latest quarter) data comparison
* 1 Y represents yearly comparison
* 3 Y represents 3-year rolling average
* TTM represents Trailing Twelve Months
* CAGR represents Compound Annual Growth Rate over 3 years
* M.Cap represents Market Capitalization
* P/E represents Price to Earnings ratio
* P/S represents Price to Sales ratio
* P/BV represents Price to Book Value ratio
* EV/EBITDA represents Enterprise Value to EBITDA ratio
* ROE represents Return on Equity
* ROCE represents Return on Capital Employed
* ROA represents Return on Assets
* All financial figures are in INR
* N/A indicates data not available or not applicable